Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine
- 1 August 2005
- journal article
- review article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 90 (8), 4946-4954
- https://doi.org/10.1210/jc.2005-0184
Abstract
Context: Combined infusion of levothyroxine plus liothyronine, as opposed to levothyroxine alone, is the only way of restoring the concentrations of circulating TSH, T-4, and T-3 as well as those of both T-4 and T-3 in all tissues of thyroidectomized rats. Considering the substantial differences in thyroid hormone secretion, transport, and metabolism between rats and humans, whether or not combined levothyroxine plus liothyronine replacement therapy has advantages over treatment with levothyroxine alone in hypothyroid patients is still questioned. Evidence Acquisition: We conducted a systematic review of all the published controlled studies comparing treatment with levothyroxine alone with combinations of levothyroxine plus liothyronine in hypothyroid patients, identified through the Entrez-PubMed search engine. Evidence Synthesis: Nine controlled clinical trials were identified that compared treatment with levothyroxine alone and treatment with combinations of levothyroxine plus liothyronine and included a sufficient number of adult hypothyroid patients to yield meaningful results. In only one study did the combined therapy appear to have beneficial effects on the mood, quality of life, and psychometric performance of the patients over levothyroxine alone. These results have not been confirmed by later studies using either T-3 substitution protocols or approaches with fixed combinations of levothyroxine plus liothyronine, including those based on the physiological proportion in which T-3 and T-4 are secreted by the human thyroid. However, in some of these studies the patients preferred levothyroxine plus liothyronine combinations, for reasons not explained by changes in the psychological and psychometric tests employed. Yet patients' preference should be balanced against the possibility of adverse events resulting from the addition of liothyronine to levothyroxine, even in the small doses used in these studies. Conclusions: Until clear advantages of levothyroxine plus liothyronine are demonstrated, the administration of levothyroxine alone should remain the treatment of choice for replacement therapy of hypothyroidism.Keywords
This publication has 21 references indexed in Scilit:
- Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well‐being and cognitive performance in hypothyroidismClinical Endocrinology, 2004
- Combined Levotriiodothyronine and Levothyroxine Therapy for Hypothyroidism: Are We a Step Closer to the Magic Formula?Thyroid®, 2004
- Thyroxine Plus Low-Dose, Slow-Release Triiodothyronine Replacement in Hypothyroidism: Proof of PrincipleThyroid®, 2004
- Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma.Endocrine-Related Cancer, 2003
- Psychological well-being in patients on 'adequate' doses of L-thyroxine: results of a large, controlled community-based questionnaire studyClinical Endocrinology, 2002
- Thyroxine vs Thyroxine Plus Triiodothyronine in Treatment of Hypothyroidism After Thyroidectomy for Graves' DiseaseEndocrine, 2002
- Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidismInternational Journal of Neuropsychopharmacology, 2000
- Thyroid Hormone Replacement — One Hormone or Two?New England Journal of Medicine, 1999
- Effects of Thyroxine as Compared with Thyroxine plus Triiodothyronine in Patients with HypothyroidismNew England Journal of Medicine, 1999
- L-Thyroxine Dosage: A Reevaluation of Therapy with Contemporary PreparationsAnnals of Internal Medicine, 1986